APOBEC3B and CD274 as Combined Biomarkers for Predicting Response to Immunotherapy in Urothelial Carcinoma of the Bladder

Figure 3

Mutations in the high and low A3B expression groups in the TCGA-BLCA. (a) Mutations in the A3B high expression group. (b) Mutations in the A3B low expression group. (c) Waterfall plot showing the top 20 mutated genes in the A3B high expression group. (d) Waterfall plot showing the top 20 mutated genes in the A3B low expression group.

(a)

(b)

(c)

(d)

(e)